How much is the ringworm treatment market worth, and how is it expected to expand?
The ringworm treatment market size has grown strongly in recent years. It will grow from $11.50 billion in 2024 to $12.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising prevalence of fungal infections, increasing awareness of hygiene and personal care, growing availability of over-the-counter antifungal medications, rising adoption of topical antifungal treatments, and growing incidence of immunocompromised conditions.
The ringworm treatment market size is expected to see strong growth in the next few years. It will grow to $15.14 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growing demand for combination therapies, rising prevalence of diabetes and other immunosuppressive conditions, expansion of telemedicine for dermatological treatments, increasing research on novel antifungal compounds, and rising consumer preference for natural and herbal antifungal products. Major trends in the forecast period include the development of nanotechnology-based antifungal treatments, the growing use of artificial intelligence in fungal infection diagnosis, the rising demand for prescription-based antifungal therapies, the expansion of direct-to-consumer antifungal brands, and the increasing integration of antifungal treatments in skincare products.
Get Your Free Sample of The Global Ringworm Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21279&type=smp
Which industry factors have accelerated the ringworm treatment market’s expansion?
The rising prevalence of fungal infections is expected to propel the growth of the ringworm treatment market going forward. Fungal infections are diseases caused by the overgrowth or invasion of fungi in the body, leading to symptoms that can affect various organs and tissues. The rising prevalence of fungal infections is due to factors such as increased use of immunosuppressive treatments, global warming, and the growing number of individuals with compromised immune systems. Ringworm treatment addresses fungal infections by offering effective antifungal therapies that prevent spread, reduce complications, and manage infection rates, especially in vulnerable populations. For instance, in November 2024, according to the UK Health Security Agency (UKHSA), a UK-based government agency, England saw a 4% rise in bloodstream infections in 2022 caused by yeast compared to the previous year, highlighting an upward trend in fungal-related health issues. Furthermore, in September 2024, according to the International Society For Infectious Diseases, a US-based non-profit organization, global estimates indicate that invasive fungal infections occur at an annual rate of 6.5 million cases, leading to approximately 3.8 million deaths, with 2.5 million directly attributed to these infections. Every year, over 2.1 million people develop invasive aspergillosis. Therefore, the rising incidence of fungal infections is propelling the growth of the ringworm treatment market.
Improvement In Healthcare Facilities Drives Growth Of The Market
The improvement of healthcare facilities is expected to propel the growth of the ringworm treatment market going forward. Healthcare facilities are establishments that offer medical care and services, such as hospitals, clinics, and diagnostic centers, to treat and support patients. Healthcare facilities are improving due to several factors such as increased investment in healthcare infrastructure, a focus on patient-centered care, population growth, and aging. Ringworm treatment supports the improvement of healthcare facilities by fostering the development of specialized dermatological care, enhancing patient education on fungal infections, and driving the adoption of effective, accessible treatment options, which in turn helps healthcare systems expand their capacity to address skin-related diseases more efficiently and improve overall public health outcomes. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from the previous year when there were 6,093 hospitals. Therefore, the improvement of healthcare facilities is driving the growth of the ringworm treatment market.
What are the primary segments of the ringworm treatment market?
The ringworm treatment market covered in this report is segmented –
1) By Drug Classes: Antifungals, Combination Drugs
2) By Treatment Types: Tinea Corpois, Tinea Pedis, Tinea Cruris, Tinea Capitis, Tinea Manuum, Other Treatment Types
3) By Route Of Administrations: Topical, Oral, Parenteral
4) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Antifungals: Topical Antifungals, Oral Antifungals, Antifungal Shampoos
2) By Combination Drugs: Antifungal Plus Steroid Combinations, Antifungal Plus Antiseptic Combinations
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/ringworm-treatment-global-market-report
Which firms are leading the ringworm treatment market?
Major companies operating in the ringworm treatment market are Pfizer Inc., Merck & Co. Inc., Bayer Healthcare, Sanofi-Aventis, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc (GSK), Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr Reddy’s Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Zydus Group, Glenmark Pharmaceuticals Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Enzon Pharmaceuticals
Which market trends are set to define the future of the ringworm treatment market?
Major companies operating in the ringworm treatment market are focusing on developing innovations, such as full-cycle skin infection control formulations, to provide more effective and longer-lasting treatments for ringworm and other fungal skin infections. A full-cycle skin infection control formulation is a treatment designed to address all stages of a skin infection, from eliminating the pathogen to preventing recurrence, soothing inflammation, and promoting overall skin healing. For instance, in May 2022, Bayer AG, a Germany-based pharmaceutical company, launched the new and improved range of Canesten, an antifungal brand. Canesten offers several unique features that enhance its effectiveness and consumer appeal. The updated Canesten product line introduces a new, advanced formulation designed to provide faster relief from fungal infections while being gentle on the skin. The relaunch focuses on offering a full-cycle treatment, combining antifungal, anti-inflammatory, and skin-soothing properties in one product, ensuring not only effective infection control but also long-term prevention of recurrence.
Which geographic trends are shaping the ringworm treatment market, and which region has the highest market share?
North America was the largest region in the ringworm treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ringworm treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Ringworm Treatment Market Report 2025 Offer?
The ringworm treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Ringworm treatment involves the use of medications to eliminate the fungal infection caused by dermatophytes, relieve symptoms such as itching and redness, and prevent the spread of the contagious condition to other body areas or individuals. In addition to medication, maintaining proper hygiene, keeping affected areas dry, and avoiding direct contact with infected individuals or surfaces effectively manages and prevents the recurrence of ringworm infections.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21279
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
